tirzepatide bmi criteria NICE Recommends Tirzepatide: A Game-Changer for Obesity Management 🔵Eligibility Criteria: ▪️BMI ≥35 kg/m² + at least 1 weight-related comorbidity. ▪️Lower thresholds for specific ethnic groups. 🔵Continuation of Treatment: ▪️≥5% weight loss 📢 Important Update: New Prescribing

Read more on MIMS Pharma To view or add a comment, sign in Overview of GLP-1 Analogue Drugs: Brands, Companies & Clinical Uses GLP-1 analogues have transformed the treatment landscape for Type 2 Diabetes and obesity management offering better glycemic control, cardiovascular benefits, and effective weight loss

These adverse reactions may be precursors to more serious side effects like stomach paralysis (gastroparesis) and intestinal blockages

Thicker solutions benefit from slightly slower injection speeds and warmer temperatures

5-Methyltetrahydrofolate is used to convert homocysteine (a potentially toxic amino acid) to methionine by the enzyme methionine synthase

J., Nielsen, J

Hi Good My husband ( a board certified MD) and I appreciate the quick delivery and quality of your product